Inventor
Olga Vasiljeva
Inventor
US
Overview
Patents· 15 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides28%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C12NMicroorganisms or enzymes7%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
C12YEnzymes4%
B01DSeparation2%
PatentTitleYear
12,589,164Protease-cleavable substrates and methods of use thereof202612,570,748Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof202612,551,571Protease-cleavable substrates and methods of use thereof202612,502,439—202512,498,367Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof202512,459,999Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof202512,049,505Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof202411,890,354Activatable antibodies that bind epidermal growth factor receptor and methods thereof202411,884,746Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof202411,867,695Compositions and methods for detecting protease activity in biological systems202411,814,410Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof202311,548,943Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof202311,548,944Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof202311,472,875Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof202211,174,316Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2026Patents assigned to CYTOMX THERAPEUTICS INC (15)· patent assignee history
2021–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CYTOMX THERAPEUTICS INC | 15 | 2021–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 15 | 2021–2026 |